27. Pharmacology of Drugs with Dr David Nichols episode artwork

EPISODE · Sep 8, 2020 · 43 MIN

27. Pharmacology of Drugs with Dr David Nichols

from The Drug Science Podcast · host Fascinate Productions

A special treat this week as the two titans of psychopharmacology discuss the medicinal chemistry of psychedelics. Dr Nichols is the Founding President of the Heffter Research Institute, an organisation designed to promote research of the highest scientific quality with psychedelics in order to contribute to a greater understanding of the mind leading to the improvement of the human condition, and to alleviate suffering.Professor Nutt and Dr Nichols answer some burning questions of psychedelic science such as: What will come to market first, LSD, Psilocybin or MDMA? Could microdosing be dangerous? Is there such a thing as DMT tolerance? David E. Nichols, is currently an Adjunct Professor in the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill, NC. He is a Distinguished Professor Emeritus at the Purdue University College of Pharmacy, and was the Robert C. and Charlotte P. Anderson Chair in Pharmacology, where he carried out teaching and research for 38 years prior to his retirement in 2012. A major focus of his research was on substances known as hallucinogens, known more popularly as psychedelics. Widely published in the scientific literature and internationally recognized for his research on centrally active drugs, he has studied all of the major classes of psychedelic agents, including LSD and other lysergic acid derivatives, psilocybin and the tryptamines, and phenethylamines related to mescaline. Among scientists, he is recognized as one of the foremost international experts on the medicinal chemistry of psychedelics.Shulgin Mescaline MDMA LSD Psilocybin Entactogen vs Empathogen Drugs Enforcement Agency Salvia Heffter Research Institute Arthur Heffter Psilocybin for depression trial Psilocybin for OCD Yale study Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsN,N-dimethyltryptamine and the pineal gland: Separating fact from mythA Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic ExperienceFen-phen Weightloss drug Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and AeruginascinBecome a Drug Science Community Member: https://www.donate.drugscience.org.uk/Twitter: @ProfDavidNutt @Drug_ScienceA Fascinate Productions podcast for Drug Science ★ Support this podcast ★

Episode metadata supplied by the publisher feed · Published Sep 8, 2020

Embed this episode

Psychedelics have transcended from counter-culture to the mainstream. Dr. David Nichols has been at the forefront of pharmacology and chemistry throughout this transition and has been shifting this paradigm since 1969.

Distinct summary based on available episode metadata or transcript content.

Ready to play

27. Pharmacology of Drugs with Dr David Nichols

0:00 43:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Drug Science Podcast?

This episode is 43 minutes long.

When was this The Drug Science Podcast episode published?

This episode was published on September 8, 2020.

Can I download this The Drug Science Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!